Clinical Trial Update: Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of radiotherapy for oligoprogressive hepatocellular carcinoma after first-line PD-1 therapy; currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: HCC - Hepatocellular Carcinoma, Radiotherapy | Phase 2 | Status: RECRUITING